ad image

Publication

1 / 1
Vanda Pharmaceuticals
Announcement

Vanda Pharmaceuticals Announces the Publication of an Article "Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"

Vanda Pharmaceuticals

PR-02-25-NI-25Feb 24, 2025
Harbour BioMed
Clinical Trials

Harbour BioMed Announces the Phase I Study Results in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors

Harbour BioMed

PR-10-24-NI-39Oct 11, 2024
MiMedx
Clinical Data

MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International

MiMedx

PR-M08-18-NI-040Aug 10, 2018
1 / 1